Edward G Shaw
Overview
Explore the profile of Edward G Shaw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
3765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rapp S, Dressler E, Brown W, Wade 3rd J, Le-Lindqwister N, King D, et al.
J Clin Oncol
. 2024 May;
42(21):2546-2557.
PMID: 38709986
Purpose: To test efficacy of donepezil, a cognitive enhancer, to improve memory in breast cancer survivors who report cancer-related cognitive impairment 1-5 years postchemotherapy. Patients And Methods: Adult female BCS...
2.
Hughes R, Ip E, Urbanic J, Hu J, Weaver K, Lively M, et al.
Clin Breast Cancer
. 2022 Oct;
22(8):762-770.
PMID: 36216768
Introduction: Smoking during breast radiotherapy (RT) may be associated with radiation-induced skin injury (RISI). We aimed to determine if a urinary biomarker of tobacco smoke exposure is associated with increased...
3.
Bell E, Zhang P, Shaw E, Buckner J, Barger G, Bullard D, et al.
J Clin Oncol
. 2020 Jul;
38(29):3407-3417.
PMID: 32706640
Purpose: NRG Oncology/RTOG 9802 (ClinicalTrials.gov Identifier: NCT00003375) is a practice-changing study for patients with WHO low-grade glioma (LGG, grade II), as it was the first to demonstrate a survival benefit...
4.
Breen W, Anderson S, Carrero X, Brown P, Ballman K, ONeill B, et al.
Neuro Oncol
. 2020 Feb;
22(6):830-837.
PMID: 32002556
Background: The optimal radiation dose for adult supratentorial low-grade glioma is unknown. The aim of this study was to provide a final update on oncologic and cognitive outcomes of high-dose...
5.
Lee E, Takita C, Wright J, Slifer S, Martin E, Urbanic J, et al.
Hum Genomics
. 2019 Jun;
13(1):28.
PMID: 31196165
Background: Adjuvant radiotherapy (RT) can increase the risk of developing pain; however, the molecular mechanisms of RT-related pain remain unclear. The current study aimed to identify susceptibility loci and enriched...
6.
Cramer C, Cummings T, Andrews R, Strowd R, Rapp S, Shaw E, et al.
Curr Treat Options Oncol
. 2019 Apr;
20(5):42.
PMID: 30963289
Patients with either primary or metastatic brain tumors quite often have cognitive impairment. Maintaining cognitive function is important to brain tumor patients and a decline in cognitive function is generally...
7.
Cramer C, Alphonse-Sullivan N, Isom S, Metheny-Barlow L, Cummings T, Page B, et al.
J Cancer Res Clin Oncol
. 2018 Nov;
145(2):337-344.
PMID: 30417218
Introduction: Radiation-induced cognitive decline (RICD) is a late effect of radiotherapy (RT) occurring in 30-50% of irradiated brain tumor survivors. In preclinical models, pioglitazone prevents RICD but there are little...
8.
Cramer C, McKee N, Case L, Chan M, Cummings T, Lesser G, et al.
J Neurooncol
. 2018 Nov;
141(1):235-244.
PMID: 30406339
Introduction: There is no accepted classification of cognitive impairment in cancer survivors. We assess the extent of mild cognitive impairment (MCI) syndrome in brain tumor survivors using criteria adapted from...
9.
Hu J, Urbanic J, Case L, Takita C, Wright J, Brown D, et al.
J Clin Oncol
. 2018 Jul;
36(24):2473-2482.
PMID: 29989859
Purpose This study examined an inflammatory biomarker, high-sensitivity C-reactive protein (hsCRP), in radiotherapy (RT)-induced early adverse skin reactions or toxicities in breast cancer. Patients and Methods Between 2011 and 2013,...
10.
Gifford A, Lawrence J, Baker L, Balcueva E, Case D, Craft S, et al.
J Oncol Research
. 2018 Jun;
1(1).
PMID: 29873324
Background: In this analysis we use the National Institute on Aging/Alzheimer's Association (NIA/AA) criteria to identify Mild Cognitive Impairment (MCI) in a sample of breast cancer survivors treated with chemotherapy....